ELIZABETH BANCROFT: Open Payments
NPI 1871292482 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,075 in 116 payments from 31 companies in 2025. Trend: 2023 $1,615 · 2024 $2,952 · 2025 $3,075
Food & beverage: $3,075
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 21 | $566 |
| ABBVIE INC. | 17 | $374 |
| Novartis Pharmaceuticals Corporation | 7 | $324 |
| EMD Serono, Inc. | 4 | $192 |
| Biogen, Inc. | 6 | $176 |
| Lilly USA, LLC | 8 | $172 |
| TG Therapeutics, Inc. | 7 | $164 |
| LivaNova USA, Inc. | 1 | $145 |
| SK Life Science, Inc. | 4 | $105 |
| Genentech USA, Inc. | 4 | $82 |
Products named: PONVORY, KESIMPTA, QULIPTA, BRIUMVI, KISUNLA, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, AVONEX, BOTOX.
Industry payments across IN — which companies pay providers there.
